Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA Committee Caps...

NPPA Committee Caps Price of Akums' Cetirizine Eye Drops at Rs 14.42 per ml

Written By : Susmita Roy Published On 2026-01-03T16:49:16+05:30  |  Updated On 3 Jan 2026 4:49 PM IST
NPPA Committee Caps Price of Akums Cetirizine Eye Drops at Rs 14.42 per ml
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Cetirizine Hydrochloride IP eq. to Cetirizine 0.24 % w/v plus Benzalkonium Chloride Solution IP 0.02 % v/v (as preservative) ophthalmic eye drops at Rs 14.42 per ml for a 5 ml pack for products manufactured by Akums Drugs & Pharmaceuticals and marketed by Dr. Reddy's Laboratories and Mankind Pharma, following recommendations of its Multidisciplinary Committee of Experts (MDC).

The matter was deliberated during the 73rd meeting of the Multidisciplinary Committee of Experts (MDC) held on 25 November 2025, wherein the Committee examined retail price fixation of each ml Contains: Cetirizine Hydrochloride IP eq. to Cetirizine 0.24 % w/v + Benzalkonium Chloride Solution IP 0.02 % v/v (as preservative) for: (i) Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) and Dr. Reddy’s Laboratories Ltd. (Marketer) (F.No. 4864); and (ii) M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer) (F. No. 4938)

The applicants have filed the application for retail price fixation of each ml containing Cetirizine Hydrochloride IP Eq. to Cetirizine 0.24% w/v Benzalkonium Chloride Solution IP 0.02% v/v (As preservative) Eye Drops (Pack size-5ml). The data for the subject formulation was not available in the Pharmarack database.

Therefore, the matter was placed for the deliberations of the Multidisciplinary Committee of Experts (MDC) in its 73rd meeting held on 25.11.2025, wherein the Committee directed to explore details of other antihistamine eye drops.

Also Read: Serum Institute to Get NPPA Nod to Discontinue Two Pack Sizes of Tetanus Toxoid Vaccine

In view of the deliberations, in the 73rd meeting of the MDC, the market-based data as available with NPPA was examined. It was observed that eye drops containing formulations of Azelastine, Epinastine and Olopatadine, which are also second-generation antihistamine like Cetirizine, are available in the market. (Source: WAO Journal, September 2008).

The Committee noted that tablet forms of Cetirizine as well as of the above formulations are available in the market. However, there is substantial price difference among the prices of these tablets.

Therefore, the Committee opined that these Ophthalmic eye drops are not comparable with the eye drop of Cetirizine.

The Committee observed that the process for manufacturing eye drops is different than the manufacturing process of tablets and additional steps are involved in converting API to Ophthalmic formulations with respect to sterility, stability, irritability, etc., which makes Ophthalmic formulations more expensive than the Tablet formulation.

In order to understand the trend of the price differential, the Committee examined the data in respect of 3 scheduled and 2 non-scheduled formulations which are available both in tablet as well as eye drop form.

Based on the analysis of the said data, the Committee observed that the average ratio of Eye drops to Tablets of same strength of Moxifloxacin, Ciprofloxacin, Prednisolone, Chloramphenicol and Ketorolac works out to 32.47.

In view of the above analysis, the Committee decided to apply said average ratio to the price of Cetirizine tablet to arrive at the price of Cetirizine eye drops. Accordingly, the retail price is worked out as below:

Calculation

Applied formulation: Each ml containing Cetirizine Hydrochloride IP Eq. to Cetirizine 0.24% or 240 mg in 100ml; Pack size is 5 ml containing 12mg

A. Derived price of Cetirizine Tablet 12mg (Note 1)

Rs.2.22

B. Ratio of eye drops to Tablets of same strength of other formulation

32.47 times

C. Worked out price of Cetirizine 0.24% w/v eye drop (pack of 5 ml containing 12mg of Cetirizine)

(AXB)

Rs.72.08/pack of 5 ml i.e. Rs.14.42/ml

D. Claimed Price per pack of 5 ml

(i) M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Dr. Reddy’s Laboratories Ltd. (Marketer);

(i) Rs.30 per ML

(ii) M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer)

(ii) Rs.55 per ML

E. Recommended retail price (Lower of worked out and claimed price

Rs.14.42 per ML for both applications

Note-1:

(i) The retail price of Cetirizine Tablet 12mg based on formula recommended in the Pronab Sen

Committee report is as below:

Ceiling price of Cetirizine Tablet 10mg is Rs. 1.91 per tablet.

Derived retail price as per recommendation of Pronab Sen Committee:

P(s) = P*[1+a.{(s-s*)/s*}]

Where P(s) = Price ceiling of the strength s

P*= Price ceiling for reference strength s*

s = strength in terms of API content

s*=reference strength

A= 0.8 for tablet / capsule and 0.7 for injectables.

=1.91 [1+0.8{(12-10)/10}]

=Rs. 2.22 per tablet (excluding GST)

Also Read:935 Essential Medicines Saw 17% Price Cut, Minister Informs Parliament
npparetail pricecetrizineBenzalkonium chlorideeye dropDr Reddy Labakums drugs & pharmamankind phamadr reddys lab
Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Show Full Article
    Next Story

    Editorial

    Acne On Chest, Back and Shoulders: Expert Insights with Dermatologist Dr Rajat Kandhari

    Acne On Chest, Back and Shoulders: Expert Insights with Dermatologist Dr Rajat Kandhari

    Evaluation of Biologic Efficacy and Cost per NNT in Moderate-to-Severe Psoriasis: Indian Analysis

    Evaluation of Biologic Efficacy and Cost per NNT in Moderate-to-Severe Psoriasis: Indian Analysis

    U.S. FDA Grants Approval for Ranitidine Comeback

    U.S. FDA Grants Approval for Ranitidine Comeback

    Dapagliflozin and Sitagliptin FDC in T2D with Heart Failure: 2025 Indian Practice Review

    Dapagliflozin and Sitagliptin FDC in T2D with Heart Failure: 2025 Indian Practice Review

    Importance of Early Aggressive Glucose Control - Approach in 2026

    Importance of Early Aggressive Glucose Control - Approach in 2026

    View All

    Journal Club Today

    Statins Reduce Mortality and Cardiovascular Events Even in Low-Risk Type 2 Diabetes: Study

    Statins Reduce Mortality and Cardiovascular Events Even in Low-Risk Type 2 Diabetes: Study

    View All

    Health News Today

    Health Bulletin 24/January/2026

    Health Bulletin 24/January/2026

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok